Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 46

    1.

    Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals.

    Rupprecht CE, Briggs D, Brown CM, Franka R, Katz SL, Kerr HD, Lett S, Levis R, Meltzer MI, Schaffner W, Cieslak PR.

    Vaccine. 2009 Nov 27;27(51):7141-7148.PMID: 19925944 [PubMed - as supplied by publisher]Related articles

    2.

    A community-based outbreak of severe respiratory illness caused by human adenovirus serotype 14.

    Lewis PF, Schmidt MA, Lu X, Erdman DD, Campbell M, Thomas A, Cieslak PR, Grenz LD, Tsaknardis L, Gleaves C, Kendall B, Gilbert D.

    J Infect Dis. 2009 May 15;199(10):1427-34.PMID: 19351259 [PubMed - indexed for MEDLINE]Related articles

    3.

    Food handler assessment in Oregon.

    DeBess EE, Pippert E, Angulo FJ, Cieslak PR.

    Foodborne Pathog Dis. 2009 Apr;6(3):329-35.PMID: 19341317 [PubMed - indexed for MEDLINE]Related articles

    4.

    Antibiotic resistance patterns in invasive group B streptococcal isolates.

    Castor ML, Whitney CG, Como-Sabetti K, Facklam RR, Ferrieri P, Bartkus JM, Juni BA, Cieslak PR, Farley MM, Dumas NB, Schrag SJ, Lynfield R.

    Infect Dis Obstet Gynecol. 2008;2008:727505. Epub 2009 Feb 5.PMID: 19223967 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Vaccine-era varicella epidemiology and vaccine effectiveness in a public elementary school population, 2002-2007.

    Lee LE, Ho H, Lorber E, Fratto J, Perkins S, Cieslak PR.

    Pediatrics. 2008 Jun;121(6):e1548-54.PMID: 18519459 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Salmonellosis outcomes differ substantially by serotype.

    Jones TF, Ingram LA, Cieslak PR, Vugia DJ, Tobin-D'Angelo M, Hurd S, Medus C, Cronquist A, Angulo FJ.

    J Infect Dis. 2008 Jul 1;198(1):109-14.PMID: 18462137 [PubMed - indexed for MEDLINE]Related articles

    7.

    Reactive arthritis following culture-confirmed infections with bacterial enteric pathogens in Minnesota and Oregon: a population-based study.

    Townes JM, Deodhar AA, Laine ES, Smith K, Krug HE, Barkhuizen A, Thompson ME, Cieslak PR, Sobel J.

    Ann Rheum Dis. 2008 Dec;67(12):1689-96. Epub 2008 Feb 13.PMID: 18272671 [PubMed - indexed for MEDLINE]Related articles

    8.

    Invasive group A streptococcal infection in older adults in long-term care facilities and the community, United States, 1998-2003.

    Thigpen MC, Richards CL Jr, Lynfield R, Barrett NL, Harrison LH, Arnold KE, Reingold A, Bennett NM, Craig AS, Gershman K, Cieslak PR, Lewis P, Greene CM, Beall B, Van Beneden CA; Active Bacterial Core surveillance / Emerging Infections Program Network.

    Emerg Infect Dis. 2007 Dec;13(12):1852-9.PMID: 18258035 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004.

    O'Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A, Albanese BA, Farley MM, Barrett NL, Spina NL, Beall B, Harrison LH, Reingold A, Van Beneden C; Active Bacterial Core Surveillance Team.

    Clin Infect Dis. 2007 Oct 1;45(7):853-62. Epub 2007 Aug 29.PMID: 17806049 [PubMed - indexed for MEDLINE]Related articles

    10.

    Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA.

    MacDougall L, Kidd SE, Galanis E, Mak S, Leslie MJ, Cieslak PR, Kronstad JW, Morshed MG, Bartlett KH.

    Emerg Infect Dis. 2007 Jan;13(1):42-50.PMID: 17370514 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Clostridium difficile-associated disease in Oregon: increasing incidence and hospital-level risk factors.

    Chandler RE, Hedberg K, Cieslak PR.

    Infect Control Hosp Epidemiol. 2007 Feb;28(2):116-22. Epub 2007 Jan 31.PMID: 17265391 [PubMed - indexed for MEDLINE]Related articles

    12.

    Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donor.

    Tugwell BD, Patel PR, Williams IT, Hedberg K, Chai F, Nainan OV, Thomas AR, Woll JE, Bell BP, Cieslak PR.

    Ann Intern Med. 2005 Nov 1;143(9):648-54.PMID: 16263887 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine.

    Lexau CA, Lynfield R, Danila R, Pilishvili T, Facklam R, Farley MM, Harrison LH, Schaffner W, Reingold A, Bennett NM, Hadler J, Cieslak PR, Whitney CG; Active Bacterial Core Surveillance Team.

    JAMA. 2005 Oct 26;294(16):2043-51.PMID: 16249418 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Seroprevalence of hepatitis B and C in juvenile detention entrants, Oregon, 1994-1996.

    Thomas AR, Keene WE, Cieslak PR.

    J Adolesc Health. 2005 Nov;37(5):410-3.PMID: 16227130 [PubMed - indexed for MEDLINE]Related articles

    15.

    Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections.

    Flannery B, Schrag S, Bennett NM, Lynfield R, Harrison LH, Reingold A, Cieslak PR, Hadler J, Farley MM, Facklam RR, Zell ER, Whitney CG; Active Bacterial Core Surveillance/Emerging Infections Program Network.

    JAMA. 2004 May 12;291(18):2197-203.PMID: 15138241 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Chicken consumption is a newly identified risk factor for sporadic Salmonella enterica serotype Enteritidis infections in the United States: a case-control study in FoodNet sites.

    Kimura AC, Reddy V, Marcus R, Cieslak PR, Mohle-Boetani JC, Kassenborg HD, Segler SD, Hardnett FP, Barrett T, Swerdlow DL; Emerging Infections Program FoodNet Working Group.

    Clin Infect Dis. 2004 Apr 15;38 Suppl 3:S244-52.PMID: 15095196 [PubMed - indexed for MEDLINE]Related articles

    17.

    Hospitalizations and deaths due to Salmonella infections, FoodNet, 1996-1999.

    Kennedy M, Villar R, Vugia DJ, Rabatsky-Ehr T, Farley MM, Pass M, Smith K, Smith P, Cieslak PR, Imhoff B, Griffin PM; Emerging Infections Program FoodNet Working Group.

    Clin Infect Dis. 2004 Apr 15;38 Suppl 3:S142-8.PMID: 15095183 [PubMed - indexed for MEDLINE]Related articles

    18.

    FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States.

    Voetsch AC, Van Gilder TJ, Angulo FJ, Farley MM, Shallow S, Marcus R, Cieslak PR, Deneen VC, Tauxe RV; Emerging Infections Program FoodNet Working Group.

    Clin Infect Dis. 2004 Apr 15;38 Suppl 3:S127-34.PMID: 15095181 [PubMed - indexed for MEDLINE]Related articles

    19.

    Hepatitis B vaccine coverage among infants born to women without prenatal screening for hepatitis B virus infection: effects of the Joint Statement on Thimerosal in Vaccines.

    Thomas AR, Fiore AE, Corwith HL, Cieslak PR, Margolis HS.

    Pediatr Infect Dis J. 2004 Apr;23(4):313-8.PMID: 15071284 [PubMed - indexed for MEDLINE]Related articles

    20.

    Chickenpox outbreak in a highly vaccinated school population.

    Tugwell BD, Lee LE, Gillette H, Lorber EM, Hedberg K, Cieslak PR.

    Pediatrics. 2004 Mar;113(3 Pt 1):455-9.PMID: 14993534 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Consumer attitudes and use of antibiotics.

    Vanden Eng J, Marcus R, Hadler JL, Imhoff B, Vugia DJ, Cieslak PR, Zell E, Deneen V, McCombs KG, Zansky SM, Hawkins MA, Besser RE.

    Emerg Infect Dis. 2003 Sep;9(9):1128-35.PMID: 14519251 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.

    Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, Facklam RR, Jorgensen JH, Schuchat A; Active Bacterial Core Surveillance of the Emerging Infections Program Network.

    N Engl J Med. 2003 May 1;348(18):1737-46.PMID: 12724479 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Alfalfa seed decontamination in a Salmonella outbreak.

    Gill CJ, Keene WE, Mohle-Boetani JC, Farrar JA, Waller PL, Hahn CG, Cieslak PR.

    Emerg Infect Dis. 2003 Apr;9(4):474-9.PMID: 12702229 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Effectiveness of pharmacy policies designed to limit inappropriate vancomycin use: a population-based assessment.

    Thomas AR, Cieslak PR, Strausbaugh LJ, Fleming DW.

    Infect Control Hosp Epidemiol. 2002 Nov;23(11):683-8.PMID: 12452297 [PubMed - indexed for MEDLINE]Related articles

    25.

    U.S. medical students' rotations in epidemiology and public health at state and local health departments.

    Dannenberg AL, Quinlisk MP, Alkon E, Bera N, Cieslak PR, Davis JP, Kaye K, Paul SM, Rubin JD, Sewell CM, Touma O.

    Acad Med. 2002 Aug;77(8):799-809.PMID: 12176693 [PubMed - indexed for MEDLINE]Related articles

    26.

    Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999.

    O'Brien KL, Beall B, Barrett NL, Cieslak PR, Reingold A, Farley MM, Danila R, Zell ER, Facklam R, Schwartz B, Schuchat A.

    Clin Infect Dis. 2002 Aug 1;35(3):268-76. Epub 2002 Jul 10.PMID: 12115092 [PubMed - indexed for MEDLINE]Related articles

    27.

    Broad-range bacterial detection and the analysis of unexplained death and critical illness.

    Nikkari S, Lopez FA, Lepp PW, Cieslak PR, Ladd-Wilson S, Passaro D, Danila R, Relman DA.

    Emerg Infect Dis. 2002 Feb;8(2):188-94.PMID: 11897072 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Surveillance for unexplained deaths and critical illnesses due to possibly infectious causes, United States, 1995-1998.

    Hajjeh RA, Relman D, Cieslak PR, Sofair AN, Passaro D, Flood J, Johnson J, Hacker JK, Shieh WJ, Hendry RM, Nikkari S, Ladd-Wilson S, Hadler J, Rainbow J, Tappero JW, Woods CW, Conn L, Reagan S, Zaki S, Perkins BA.

    Emerg Infect Dis. 2002 Feb;8(2):145-53.PMID: 11897065 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Group A streptococcal puerperal sepsis preceded by positive surveillance cultures.

    Stefonek KR, Maerz LL, Nielsen MP, Besser RE, Cieslak PR.

    Obstet Gynecol. 2001 Nov;98(5 Pt 1):846-8.PMID: 11704180 [PubMed - indexed for MEDLINE]Related articles

    30.

    Macrolide resistance among invasive Streptococcus pneumoniae isolates.

    Hyde TB, Gay K, Stephens DS, Vugia DJ, Pass M, Johnson S, Barrett NL, Schaffner W, Cieslak PR, Maupin PS, Zell ER, Jorgensen JH, Facklam RR, Whitney CG; Active Bacterial Core Surveillance/Emerging Infections Program Network.

    JAMA. 2001 Oct 17;286(15):1857-62.PMID: 11597287 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    A nosocomial outbreak of fluoroquinolone-resistant salmonella infection.

    Olsen SJ, DeBess EE, McGivern TE, Marano N, Eby T, Mauvais S, Balan VK, Zirnstein G, Cieslak PR, Angulo FJ.

    N Engl J Med. 2001 May 24;344(21):1572-9.PMID: 11372008 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States.

    Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, Reingold A, Lefkowitz L, Cieslak PR, Cetron M, Zell ER, Jorgensen JH, Schuchat A; Active Bacterial Core Surveillance Program of the Emerging Infections Program Network.

    N Engl J Med. 2000 Dec 28;343(26):1917-24.PMID: 11136262 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Emergence of antimicrobial-resistant shigellosis in Oregon.

    Replogle ML, Fleming DW, Cieslak PR.

    Clin Infect Dis. 2000 Mar;30(3):515-9.PMID: 10722437 [PubMed - indexed for MEDLINE]Related articles

    34.

    Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis.

    Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, Hadler JL, Danila R, Cieslak PR, Schuchat A.

    N Engl J Med. 2000 Jan 6;342(1):15-20.PMID: 10620644 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Tracking drug-resistant Streptococcus pneumoniae in Oregon: an alternative surveillance method.

    Chin AE, Hedberg K, Cieslak PR, Cassidy M, Stefonek KR, Fleming DW.

    Emerg Infect Dis. 1999 Sep-Oct;5(5):688-93.PMID: 10511525 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Vancomycin in Oregon: who's using it and why.

    Cieslak PR, Strausbaugh LJ, Fleming DW, Ling JM.

    Infect Control Hosp Epidemiol. 1999 Aug;20(8):557-60.PMID: 10466557 [PubMed - indexed for MEDLINE]Related articles

    37.

    Hamburger-associated Escherichia coli O157:H7 infection in Las Vegas: a hidden epidemic.

    Cieslak PR, Noble SJ, Maxson DJ, Empey LC, Ravenholt O, Legarza G, Tuttle J, Doyle MP, Barrett TJ, Wells JG, McNamara AM, Griffin PM.

    Am J Public Health. 1997 Feb;87(2):176-80.PMID: 9103093 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Evaluation of a statewide bicycle helmet law via multiple measures of helmet use.

    Ni H, Sacks JJ, Curtis L, Cieslak PR, Hedberg K.

    Arch Pediatr Adolesc Med. 1997 Jan;151(1):59-65.PMID: 9006530 [PubMed - indexed for MEDLINE]Related articles

    39.

    An outbreak of type A botulism associated with a commercial cheese sauce.

    Townes JM, Cieslak PR, Hatheway CL, Solomon HM, Holloway JT, Baker MP, Keller CF, McCroskey LM, Griffin PM.

    Ann Intern Med. 1996 Oct 1;125(7):558-63.PMID: 8815754 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Preventable disease in correctional facilities. Desmoteric foodborne outbreaks in the United States, 1974-1991.

    Cieslak PR, Curtis MB, Coulombier DM, Hathcock AL, Bean NH, Tauxe RV.

    Arch Intern Med. 1996 Sep 9;156(16):1883-8.PMID: 8790084 [PubMed - indexed for MEDLINE]Related articles

    41.

    Unexplained deaths due to possibly infectious causes in the United States: defining the problem and designing surveillance and laboratory approaches. The Unexplained Deaths Working Group.

    Perkins BA, Flood JM, Danila R, Holman RC, Reingold AL, Klug LA, Virata M, Cieslak PR, Zaki SR, Pinner RW, Khabbaz RF.

    Emerg Infect Dis. 1996 Jan-Mar;2(1):47-53. No abstract available. PMID: 8903196 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Antibodies to the serine rich Entamoeba histolytica protein (SREHP) prevent amoebic liver abscess in severe combined immunodeficient (SCID) mice.

    Zhang T, Cieslak PR, Foster L, Kunz-Jenkins C, Stanley SL Jr.

    Parasite Immunol. 1994 May;16(5):225-30.PMID: 8072766 [PubMed - indexed for MEDLINE]Related articles

    43.

    Protection of gerbils from amebic liver abscess by immunization with a recombinant Entamoeba histolytica antigen.

    Zhang T, Cieslak PR, Stanley SL Jr.

    Infect Immun. 1994 Apr;62(4):1166-70.PMID: 8132322 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Escherichia coli O157:H7 infection from a manured garden.

    Cieslak PR, Barrett TJ, Griffin PM, Gensheimer KF, Beckett G, Buffington J, Smith MG.

    Lancet. 1993 Aug 7;342(8867):367. No abstract available. PMID: 8101603 [PubMed - indexed for MEDLINE]Related articles

    45.

    Expression of a recombinant Entamoeba histolytica antigen in a Salmonella typhimurium vaccine strain.

    Cieslak PR, Zhang T, Stanley SL Jr.

    Vaccine. 1993;11(7):773-6.PMID: 8342325 [PubMed - indexed for MEDLINE]Related articles

    46.

    A severe combined immunodeficient (SCID) mouse model for infection with Entamoeba histolytica.

    Cieslak PR, Virgin HW 4th, Stanley SL Jr.

    J Exp Med. 1992 Dec 1;176(6):1605-9.PMID: 1460420 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...